Tools for cellular immunology and vaccine research the in the guinea pig: Monoclonal antibodies to cell surface antigens and cell lines

Vaccine

Volumn 30, Issue 40, 2012, Pages 5804-5811

  Schäfer, Hubert ^a   Burger, Reinhard ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Differentiation antigen; Guinea pig; Lymphocytes; Macrophages; Monoclonal antibody

Indexed keywords

MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; VACCINE;

B LYMPHOCYTE; CELL LINE; CELL POPULATION; CELL SURFACE; CELLULAR IMMUNITY; CROSS REACTION; GUINEA PIG; HUMAN; LEUKOCYTE; LYMPHOCYTE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICAL RESEARCH; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL LINE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, SURFACE; CELL LINE; GUINEA PIGS; IMMUNOPHENOTYPING; LEUKOCYTES;

EID: 84864824580     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.07.012     Document Type: Review

References (95)

1. Koch R. Die Aetiologie der Tuberkulose. Berliner Klinische Wochenschrift 1882, 19(15).
2. Gupta U.D., Katoch V.M. Animal models of tuberculosis. Tuberculosis (Edinb) 2005, 85(September-November (5-6)):277-293.
3. McMurray D.N. Guinea pig model of tuberculosis. Tuberculosis - pathogenesis, protection, and control 1994, 135-148. ASM Press, Washington, DC. B.R. Bloom (Ed.).
4. Gupta U.D., Katoch V.M. Animal models of tuberculosis for vaccine development. Indian J Med Res 2009, 129(January (1)):11-18.
5. Canning B.J., Chou Y. Using guinea pigs in studies relevant to asthma and COPD. Pulm Pharmacol Ther 2008, 21(October (5)):702-720.
6. Carter A.M. Animal models of human placentation - a review. Placenta 2007, 28(April (Suppl. A)):S41-S47.
7. Dinser R. Animal models for arthritis. Best Pract Res Clin Rheumatol 2008, 22(April (2)):253-267.
8. Maurer T. Guinea pigs in hypersensitivity testing. Methods 2007, 41(January (1)):48-53.
9. Nauta A., Knippels L., Garssen J., Redegeld F. Animal models of anaphylaxis. Curr Opin Allergy Clin Immunol 2007, 7(August (4)):355-359.
10. Ricciardolo F.L., Nijkamp F., De Rose V., Folkerts G. The guinea pig as an animal model for asthma. Curr Drug Targets 2008, 9(June (6)):452-465.
11. Wagner J.G., Harkema J.R. Rodent models of allergic rhinitis: relevance to human pathophysiology. Curr Allergy Asthma Rep 2007, 7(May (2)):134-140.
12. Xiangdong L., Yuanwu L., Hua Z., Liming R., Qiuyan L., Ning L. Animal models for the atherosclerosis research: a review. Protein Cell 2011, 2(March (3)):189-201.
13. Zosky G.R., Sly P.D. Animal models of asthma. Clin Exp Allergy 2007, 37(July (7)):973-988.
14. Carroll S.F., Guillot L., Qureshi S.T. Mammalian model hosts of cryptococcal infection. Comp Med 2007, 57(February (1)):9-17.
15. Clemons K.V., Capilla J., Stevens D.A. Experimental animal models of coccidioidomycosis. Ann N Y Acad Sci 2007, September (1111):208-224.
16. Gowen B.B., Holbrook M.R. Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses. Antiviral Res 2008, 78(April (1)):79-90.
17. Hickey A.J. Guinea pig model of infectious disease - viral infections. Curr Drug Targets 2011, 12(June (7)):1018-1023.
18. Padilla-Carlin D.J., McMurray D.N., Hickey A.J. The guinea pig as a model of infectious diseases. Comp Med 2008, 58(August (4)):324-340.
19. Silva T.M., Costa E.A., Paixao T.A., Tsolis R.M., Santos R.L. Laboratory animal models for brucellosis research. J Biomed Biotechnol 2011, 2011:518323.
20. Vanrompay D., Lyons J.M., Morre S.A. Animal models for the study of Chlamydia trachomatis infections in the female genital infection. Drugs Today (Barc) 2006, 42(March (Suppl. A)):55-63.
21. Weingartl H.M., Berhane Y., Czub M. Animal models of henipavirus infection: a review. Vet J 2009, 181(September (3)):211-220.
22. Rank R.G., Whittum-Hudson J.A. Protective immunity to chlamydial genital infection: evidence from animal studies. J Infect Dis 2010, 201(June (Suppl. 2)):S168-S177.
23. Basaraba R.J. Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies. Tuberculosis (Edinb) 2008, 88(August (Suppl. 1)):S35-S47.
24. Dharmadhikari A.S., Nardell E.A. What animal models teach humans about tuberculosis. Am J Respir Cell Mol Biol 2008, 39(November (5)):503-508.
25. Gupta U.D., Katoch V.M., McMurray D.N. Current status of TB vaccines. Vaccine 2007, 25(May (19)):3742-3751.
26. Helke K.L., Mankowski J.L., Manabe Y.C. Animal models of cavitation in pulmonary tuberculosis. Tuberculosis (Edinb) 2006, 86(September (5)):337-348.
27. Nuermberger E. Using animal models to develop new treatments for tuberculosis. Semin Respir Crit Care Med 2008, 29(October (5)):542-551.
28. O'Toole R. Experimental models used to study human tuberculosis. Adv Appl Microbiol 2010, 71:75-89.
29. Okada M., Kita Y. Tuberculosis vaccine development: the development of novel (preclinical) DNA vaccine. Hum Vaccin 2010, 6(April (4)):297-308.
30. Orme I.M. The use of animal models to guide rational vaccine design. Microbes Infect 2005, 7(May (5-6)):905-910.
31. Orme I.M. Current progress in tuberculosis vaccine development. Vaccine 2005, 23(March (17-18)):2105-2108.
32. Orme I.M. Preclinical testing of new vaccines for tuberculosis: a comprehensive review. Vaccine 2006, 24(January (1)):2-19.
33. Parida S.K., Kaufmann S.H. Novel tuberculosis vaccines on the horizon. Curr Opin Immunol 2010, 22(June (3)):374-384.
34. Reed S., Lobet Y. Tuberculosis vaccine development; from mouse to man. Microbes Infect 2005, 7(May (5-6)):922-931.
35. Horwitz M.A., Harth G., Dillon B.J., Maslesa-Galic S. Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis. Vaccine 2009, 27(January (3)):441-445.
36. Williams A., Hatch G.J., Clark S.O., Gooch K.E., Hatch K.A., Hall G.A., et al. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis (Edinb) 2005, 85(January-March (1-2)):29-38.
37. Williams A., Hall Y., Orme I.M. Evaluation of new vaccines for tuberculosis in the guinea pig model. Tuberculosis (Edinb) 2009, 89(November (6)):389-397.
38. Schleiss M.R. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model. J Clin Virol 2008, 41(March (3)):224-230.
39. McLaren D.J., Delgado V.S., Gordon J.R., Rogers MV Schistosoma mansoni: analysis of the humoral and cellular basis of resistance in guinea-pigs vaccinated with radiation-attenuated cercariae. Parasitology 1990, 100(February (Pt 1)):35-44.
40. Bartels T., Schafer H., Liebermann H., Burger R., Beyer J. T-lymphocyte responses in guinea pigs vaccinated with foot-and-mouth disease virus. Vet Immunol Immunopathol 1994, 40(March (3)):213-223.
41. Burger R., Clement L., Schroer J., Chiba J., Shevach E.M. Monoclonal antibodies to guinea pig Ia antigens. I. Production, serologic, and immunochemical characterization. J Immunol 1981, 126(January (1)):32-37.
42. Burger R., Shevach E.M. Monoclonal antibodies to guinea pig Ia antigens. II. Effect on alloantigen-, antigen-, and mitogen-induced T lymphocyte proliferation in vitro. J Exp Med 1980, 152(October (4)):1011-1023.
43. Chiba J., Chused T.M., Leiserson W.M., Zweig S.E., Shevach E.M. Production and characterization of monoclonal antibodies to guinea pig lymphoid differentiation antigens. J Immunol Methods 1983, 63(October (2)):247-261.
44. Malek T.R., Robb R.J., Shevach E.M. Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses. J Immunol 1983, 130(February (2)):747-755.
45. Zweig S.E., Ferrone S., Shevach E.M. Monoclonal antibodies directed against human Ia antigens detect an evolutionary conserved epitope on guinea pig Ia antigens with unique functional properties. J Leukoc Biol 1984, 35(January (1)):101-113.
46. Zweig S.E., Shevach E.M. Production and properties of monoclonal antibodies to guinea pig Ia antigens. Methods Enzymol 1983, 92:66-85.
47. Schafer H., Scheper R.J., Borsdorf B., Burger R. Effector functions of CD8-positive guinea pig T lymphocytes. Cell Immunol 2003, 222(April (2)):134-143.
48. Healey D.G., Agha N., Turk J.L. Behaviour of guinea pig T cells stimulated by antigen, allo-antigen and mitogen. Int Arch Allergy Appl Immunol 1988, 87(2):134-142.
49. Malek T.R., Shevach E.M. Interleukin 2-driven T lymphocyte proliferation is dependent upon a surface antigen distinct from the interleukin 2 receptor: requirements for inhibition of T-cell proliferation by monoclonal antibody 5C3. Cell Immunol 1984, 84(March (1)):85-93.
50. Schrod L., Schaefer H., Burger R. Characterization of a T-lymphocyte membrane protein involved in T-cell function: its contribution to T-cell recognition or cellular interaction. Immunology 1986, 57(April (4)):533-538.
51. Burger R., Schrod L., Schaefer H. Functionally relevant membrane proteins of human and guinea-pig T lymphocytes. Mol Immunol 1986, 23(November (11)):1149-1156.
52. Schafer H., Bartels T., Hahn G., Otto A., Burger R. T-cell-activating monoclonal antibodies, reacting with both leukocytes and erythrocytes, recognize the guinea pig Thy-1 differentiation antigen: characterization and cloning of guinea pig CD90. Cell Immunol 1999, 197(November (2)):116-128.
53. Sato H., Inaba T., Kamiya H. Production of murine monoclonal antibodies to guinea pig leukocytes and immunohistochemistry of guinea pig skin exposed to Schistosoma mansoni. Hybridoma 1997, 16(December (6)):529-536.
54. Schafer H., Baker D., Thiele B., Burger R. Structure, cellular distribution, and functional characteristics of the guinea pig leucocyte common antigen. Cell Immunol 1990, 128(July (2)):370-384.
55. Evans C.H., DiPaolo J.A. Neoplastic transformation of guinea pig fetal cells in culture induced by chemical carcinogens. Cancer Res 1975, 35(April (4)):1035-1044.
56. Jones M., Cordell J.L., Beyers A.D., Tse A.G., Mason D.Y. Detection of T and B cells in many animal species using cross-reactive anti-peptide antibodies. J Immunol 1993, 150(June (12)):5429-5435.
57. Schafer H., Burger R. Analysis of mature guinea pig T cells with a monoclonal antibody directed against a framework determinant of the T-cell receptor for antigen. Scand J Immunol 1992, 36(October (4)):587-595.
58. Burger R., Scher I., Sharrow S.O., Shevach E.M. Non-activated guinea-pig T cells and thymocytes express Ia antigens: FACS analysis with alloantibodies and monoclonal antibodies. Immunology 1984, 51(January (1)):93-102.
59. Schafer H., Burger R. Identification and functional characterization of guinea-pig CD4: antibody binding transduces a negative signal on T-cell activation. Immunology 1991, 72(February (2)):261-268.
60. Tan B.T., Ekelaar F., Luirink J., Rimmelzwaan G., De Jonge A.J., Scheper R.J. Production of monoclonal antibodies defining guinea pig T-cell surface markers and a strain 13 Ia-like antigen: the value of immunohistological screening. Hybridoma 1985, 4(Summer (2)):115-124.
61. Baker D., Healey D.G., Verghese S., Schafer H., Turk J.L. Phenotypic analysis of guinea pig Langerhans cells with antibodies directed against leucocyte surface antigens. Int Arch Allergy Appl Immunol 1988, 86(3):350-355.
62. Jarjour W.N., Asofsky R., Raine C.S., Stone S.H. Transfer of autoimmune encephalomyelitis with T lymphocytes in strain 13 guinea pigs. Cell Immunol 1986, 103(December (2)):462-468.
63. Mauer-Gross U., von Steldern D., Hadding U., Bitter-Suermann D., Burger R. Cell surface antigens on the guinea-pig macrophage: identification by monoclonal antibodies and association with the activation state. Immunology 1985, 55(July (3)):519-530.
64. Kraal G., Shiamatey-Koolma R., Hoffer M., Baker D., Scheper R. Histochemical identification of guinea-pig macrophages by monoclonal antibody MR-1. Immunology 1988, 65(December (4)):523-528.
65. Brodersen R., Bijlsma F., Gori K., Jensen K.T., Chen W., Dominguez J., et al. Analysis of the immunological cross reactivities of 213 well characterized monoclonal antibodies with specificities against various leucocyte surface antigens of human and 11 animal species. Vet Immunol Immunopathol 1998, 64(June (1)):1-13.
66. Lasco T.M., Gonzalez-Juarrero M., Saalmuller A., Lunney J.K. Cross-reaction of anti-human CD monoclonal antibodies on guinea pig cells: a summary of the guinea pig section of the HLDA8 animal homologues data. Vet Immunol Immunopathol 2007, 119(September (1-2)):131-136.
67. Saalmuller A., Aasted B. Summary of the animal homologue section of HLDA8. Vet Immunol Immunopathol 2007, 119(September (1-2)):2-13.
68. Hiromatsu K., Dascher C.C., Sugita M., Gingrich-Baker C., Behar S.M., LeClair K.P., et al. Characterization of guinea-pig group 1 CD1 proteins. Immunology 2002, 106(June (2)):159-172.
69. Forni G., Shevach E.M., Green I. Mutant lines of guinea pig L2C leukemia. I. Deletion of Ia alloantigens is associated with a loss in immunogenicity of tumor-associated transplantation antigens. Exp Med 1976, 143(May (5)):1067-1081.
70. Clark R.B., Shevach E.M. Generation of T cell colonies from responder strain 2 guinea pigs that recognize the copolymer l-glutamic acid, l-lysine in association with nonresponder strain 13 Ia antigens. J Exp Med 1982, 155(February (2)):635-640.
71. DosReis G.A., Shevach E.M. Analysis of autoreactive I region-restricted T cell colonies isolated from the guinea pig syngeneic mixed leukocyte reaction and from immune responses to conventional foreign antigens. Eur J Immunol 1985, 15(May (5)):466-472.
72. Malek T.R., Clark R.B., Alloreactive Shevach E.M. T cells from individual soft agar colonies specific for guinea pig Ia antigens. I. Production and initial characterization. J Immunol 1981, 127(August (2)):616-621.
73. Schafer H., Muller B., Bader A., Schenkel J., Burger R. Analysis of guinea pig leukocyte antigens using interspecies T cell hybrids. J Immunol Methods 1989, 118(March (2)):169-177.
74. Leo O., Foo M., Sachs D.H., Samelson L.E., Bluestone J.A. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A 1987, 84(March (5)):1374-1378.
75. Spieker-Polet H., Sethupathi P., Yam P.C., Knight K.L. Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas. Proc Natl Acad Sci U S A 1995, 92(September (20):9348-9352.
76. Behar S.M., Porcelli S.A., Beckman E.M., Brenner M.B. A pathway of costimulation that prevents anergy in CD28-T cells: B7-independent costimulation of CD1-restricted T cells. J Exp Med 1995, 182(December (6)):2007-2018.
77. Sobel R.A., Blanchette B.W., Russo M.A., Williams A.M., Colvin R.B. Anti-T cell monoclonal antibodies in vivo. II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs. J Immunol 1987, 138(April (8)):2507-2513.
78. Sobel R.A., Hanzakos J.L., Blanchette B.W., Williams A.M., Dellapelle P., Colvin R.B. Anti-T cell monoclonal antibodies in vivo. I. Inhibition of delayed hypersensitivity but not cutaneous basophil hypersensitivity reactions. J Immunol 1987, 138(April (8)):2500-2506.
79. Dilwith R., Wicher K. C.D5+ and CD5- B1-like lymphocytes in healthy guinea pig. Clin Immunol Immunopathol 1997, 85(November (2)):143-150.
80. Nagarajan U.M., O'Connell C., Rank R.G. Molecular characterization of guinea-pig (Cavia porcellus) CD8alpha and CD8beta cDNA. Tissue Antigens 2004, 63(February (2)):184-189.
81. Kaslovsky R.A., Horgan M.J., Lum H., McCandless B.K., Gilboa N., Wright S.D., et al. Pulmonary edema induced by phagocytosing neutrophils. Protective effect of monoclonal antibody against phagocyte CD18 integrin. Circ Res 1990, 67(October (4)):795-802.
82. Noonan T.C., Gundel R.H., Desai S.N., Stearns C., Barton R.W., Rothlein R., et al. The effects of an anti-CD18 antibody (R15.7) in antigen-induced airway hyperresponsiveness (AH) and cell influx in guinea pigs. Agents Actions 1991, 34(September (1-2)):211-213.
83. Hart I.J., Schafer H., Scheper R.J., Stevenson G.T. Subpopulations of guinea-pig T lymphocytes defined by isoforms of the leucocyte common antigen. Immunology 1992, 77(November (3)):377-384.
84. Nishikawa K., Matsuo S., Tamai H., Okada N., Okada H. Tissue distribution of the guinea-pig decay-accelerating factor. Immunology 1998, 95(October (2)):302-307.
85. Okada N., Tanaka H., Takizawa H., Okada H. A monoclonal antibody that blocks the complement regulatory activity of guinea pig erythrocytes and characterization of the antigen involved as guinea pig decay-accelerating factor. J Immunol 1995, 154(June (11)):6103-6111.
86. Horikawa T., Komohara Y., Kiyota E., Terasaki Y., Takagi K., Takeya M. Detection of guinea pig macrophages by a new CD68 monoclonal antibody, PM-1K. J Mol Histol 2006, 37(January 1-2):15-25.
87. Kraal G., Twisk A., Tan B., Scheper R. A surface molecule on guinea pig lymphocytes involved in adhesion and homing. Eur J Immunol 1986, 16(December (12)):1515-1519.
88. Healey D.G., Baker D., Gschmeissner S.E., Turk J.L. An antigenic determinant common to lymphocytes and Langerhans cells of the guinea pig. Int Arch Allergy Appl Immunol 1987, 82(2):120-124.
89. Shimamura T., Nakamura T., Koyama J. Demonstration of the existence of two distinct Fc receptors for IgG isotypes on guinea-pig macrophages by the use of monoclonal antibodies. Mol Immunol 1987, 24(January (1)):67-74.
90. Hoying J. Selection and histochemical identification of epithelial-like cells from guinea pig lung 1975.
91. O'Donnell R.W., Cockerell G.L. Establishment and biological properties of a guinea pig colonic adenocarcinoma cell line induced by N-methyl-N-nitrosourea. Cancer Res 1981, 41(June (6)):2372-2377.
92. Shevach E.M., Ellman L., Davie J.M., Green I. L2C Guinea pig lymphatic leukemia: a B cell leukemia. Blood 1972, 39(January (1)):1-12.
93. Green I., Forni G., Konen T., Hu C.P., Schwartz B.D., Kask A., et al. Immunological studies of the guinea pig L2C leukemia. Fed Proc 1977, 36(August (9)):2264-2267.
94. Konen T.G., Green I., Shevach E.M., Kask A.M., Schwartz B.D. Mutant lines of guinea pig L2C leukemia. III. The reaction of an alloantiserum detecting idiotypic determinants on a clonally derived guinea pig B cell leukemia with IgM and Ia molecules. J Immunol 1976, 117(November (5 Pt 2)):1966-1970.
95. Rapp H.J., Churchill W.H., Kronman B.S., Rolley R.T., Hammond W.G., Borsos T. Antigenicity of a new diethylnitrosamine-induced transplantable guinea pig hepatoma: pathology and formation of ascites variant. J Natl Cancer Inst 1968, 41(July (1)):1-7.